ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2021

November 5-9, 2021. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z
  • Abstract Number: 0443
    Safety and Efficacy of Belimumab in the Treatment of Adult Idiopathic Inflammatory Myositis (Polymyositis and Dermatomyositis)
  • Abstract Number: 0445
    Safety and Efficacy of Denosumab vs Risedronate in Patients with Glucocorticoid-Induced Osteoporosis and Rheumatoid Arthritis
  • Abstract Number: 1690
    Safety and Efficacy of Long-term Sarilumab Treatment in Patients with Active Rheumatoid Arthritis: EXTEND and MONARCH Open Label Extension Studies
  • Abstract Number: 0496
    Safety and Efficacy of Rituximab for Systemic Sclerosis: A Double-Blind, Parallel-Group Comparison, Investigators Initiated Confirmatory Randomized Clinical Trial (DESIRES Study)
  • Abstract Number: 0831
    Safety and Efficacy of Tofacitinib vs TNF Inhibitors in RA Patients Aged 50 Years or Older with One or More Cardiovascular Risks: Results from a Phase 3b/4 Randomized Safety Trial
  • Abstract Number: 0397
    Safety and Persistence of Monthly Intravenous Iloprost in Systemic Sclerosis
  • Abstract Number: 0695
    Safety and Tolerability of IVIg (Octagam 10%) in Patients with Active Dermatomyositis. Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
  • Abstract Number: 0187
    Safety and Tolerability of Nintedanib in Patients with Autoimmune Disease-Related Interstitial Lung Diseases: Pooled Data from the SENSCIS and INBUILD Trials
  • Abstract Number: 1676
    Safety of Baricitinib in Japanese Patients with Rheumatoid Arthritis (RA): The 2020 Interim Report from All-case Post Marketing Surveillance in Clinical Practice
  • Abstract Number: 0100
    Safety of COVID-19 Vaccines After First Vaccination in Patients with Rheumatic Diseases in a Patient Reported Survey
  • Abstract Number: 1545
    Safety of JAK Inhibitor in Patients with Rheumatoid Arthritis Who Developed Reactivation of Herpes Zoster Virus After Receiving JAK Inhibitor
  • Abstract Number: 1688
    Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 9.3 Years: An Updated Integrated Safety Analysis
  • Abstract Number: 1828
    Safety Profile of Ixekizumab for the Treatment of Psoriatic Arthritis and Axial Spondyloarthritis up to 3 Years: An Updated Integrated Safety Analysis
  • Abstract Number: 0730
    Safety, Tolerability, and Pharmacokinetics of an Intra-articular Corticosteroid Injection Administered 7 Days Before or After Intra-articular Lorecivivint Injection into the Same Knee of Healthy Volunteers: An Open-Label, Parallel-Arm Study
  • Abstract Number: 1689
    Safety, Tolerability, Pharmacokinetics, Receptor Occupancy, and Suppression of T-cell-Dependent Antibody Response in a Phase 1 Study with KPL-404, an anti-CD40 Monoclonal Antibody
  • Abstract Number: 0300
    Salivary Gland Epithelial Cells Transcriptomic Analysis Highlight Their Potential Involvement in Extracellular Matrix Modification in Sjögren’s Syndrome
  • Abstract Number: 0002
    Salivary Sodium Levels in the Parotid Salivary Gland of SS Patients Suggest B-cell Mediated Epithelial Sodium Channel Disruption
  • Abstract Number: 1013
    SARS-CoV-2 Antibody Phenotype and Immune Gene Expression in Multi-system Inflammatory Syndrome in Children
  • Abstract Number: 0086
    SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review
  • Abstract Number: L04
    SARS-CoV-2 Infections Among Vaccinated Individuals with Rheumatic Disease: Results from the COVID-19 Global Rheumatology Alliance Provider Registry
  • Abstract Number: 0089
    SARS-CoV-2 Seroprevalence and Seroconversion in a Systemic Lupus Erythematosus Cohort and Comparison to General Population Controls
  • Abstract Number: 1609
    SARS-CoV-2 Vaccination Willingness and Its Predictors in Patients with Chronic Inflammatory Rheumatic Diseases (CIRD)
  • Abstract Number: 1074
    Satisfaction with a Virtual Learning Collaborative Aimed at Implementing Treat to Target (TTT) in Rheumatoid Arthritis (RA)
  • Abstract Number: 1601
    Satisfaction with Telemedicine in Immunosuppressed Children and Young Adults with Autoimmune Disease During the COVID 19 Pandemic: Are Their Needs Really Met? Preliminary Data from a Single Institution
  • Abstract Number: 0755
    Satisfaction with the Process versus Outcome of Care in Total Hip and Knee Arthroplasty
  • Abstract Number: 1853
    Scleroderma Presentation in the Canadian Scleroderma Research Group Indigenous Population
  • Abstract Number: 0903
    Scoring MRI Structural Lesions in Sacroiliac Joints of Patients with Axial Spondyloarthritis: How Many Slices Are Optimal?
  • Abstract Number: 0892
    Screening for Cognitive Impairment with the Automated Neuropsychological Assessment Metrics in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1835
    Secukinumab Effects on Cardiometabolic Risk and Systemic Inflammation in Patients with Psoriasis, Psoriatic Arthritis and Axial Spondyloarthritis: Results from Post Hoc Analyses of Pooled Data from 19 Phase 3/4 Clinical Studies
  • Abstract Number: L19
    Secukinumab in Giant Cell Arteritis: A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial
  • Abstract Number: 1825
    Secukinumab Provides Clinical Improvements in Patients with Active Oligoarticular Psoriatic Arthritis: Results from a Pooled Analysis of 5 Phase 3 Studies
  • Abstract Number: 1832
    Secukinumab Therapy in Biologic-naïve vs. Biologic-experienced Patients: Real-world Effectiveness, Persistence and Safety Results from the Rheumatic Diseases Portuguese Registry
  • Abstract Number: 1424
    Secukinumab Treatment in Children and Adolescents with Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis: Efficacy and Safety Results from a Phase 3 Study
  • Abstract Number: 1824
    Secukinumab Treatment Provides Sustained Resolution of Enthesitis at Individual Joints Through 52 Weeks in a Phase 3b, Double-Blind, Randomized, Active-Controlled Study
  • Abstract Number: 0509
    Selective Inhibition of Tyrosine Kinase 2 with Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors
  • Abstract Number: 1181
    Self Directed Learning Among Internal Medicine Residents: Incorporating a New Teaching Module on Calcium Pyrophosphate Deposition in the Rheumatology Curriculum
  • Abstract Number: 0373
    Self-monitoring of Disease Activity with a Smartphone App Is Feasible in Routine Clinical Management of Patients with Axial Spondyloarthritis – a Proof of Concept Study
  • Abstract Number: 0237
    Self-perceived General Health at Start of Anti-TNF Therapy Predicts Therapeutic Response in Patients with Rheumatoid Arthritis: Analysis from the Czech Biologics Registry ATTRA
  • Abstract Number: 0371
    Self-referral Strategy for Early Diagnosis of Axial Spondyloarthritis- Preliminary Analysis from Finding Axial Spondyloarthritis Study
  • Abstract Number: 1621
    Self-reported Transition Readiness of Adolescent Patients with Rheumatologic Disease: Do the Parents Agree?
  • Abstract Number: 0176
    Semi-quantitative Chest Computed Tomography (CT) Analysis in Pediatric Rheumatologic (PR) Patients with Diffuse Lung Disease
  • Abstract Number: 0321
    Sequential Administration of Belimumab and Rituximab in Primary Sjögren’s Syndrome Reduces Minor Salivary Gland–Resident B Cells and Delays B-Cell Repopulation in Circulation
  • Abstract Number: 0932
    Sequential Treatment in Axial Spondyloarthritis – Real World Data from a Network of German Rheumatologists
  • Abstract Number: 0330
    Serologic Phenotypes Distinguish SLE Patients with Myositis And/or Interstitial Lung Disease (ILD)
  • Abstract Number: 0338
    Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1251
    Serum B Cell Activating Factor Reflects Good EULAR Response to TNF Inhibition in Patients with Rheumatoid Arthritis
  • Abstract Number: 0691
    Serum Cytokine Profiles of Patients with Adult Idiopathic Inflammatory Myopathy
  • Abstract Number: 0874
    Serum Galectin-9 and CXCL-10 but Not Their Urinary Levels Reflect Lupus Activity
  • Abstract Number: 1856
    Serum IFN Score Predicts Long Term Outcome in Limited Cutaneous SSc
  • Abstract Number: 1858
    Serum Interferon Score Is a Biomarker of Active Disease in Patients with Early Diffuse Cutaneous Systemic Sclerosis Enrolled in the Prospective Registry of Early Systemic Sclerosis (PRESS) Cohort
  • Abstract Number: 1379
    Serum Levels of the Soluble Receptor for Advanced Glycation Endproducts Are Prospectively Associated with Pulmonary Arterial Hypertension in Systemic Sclerosis
  • Abstract Number: 1206
    Serum Levels of Total IgA Anti-cyclic Citrullinated Protein Antibodies Predict 11-year Radiographic Outcome in Early Rheumatoid Arthritis
  • Abstract Number: 1091
    Serum Metabolomic Profiling Identifies Potential Biomarkers in Arthritis in the Elderly
  • Abstract Number: 0863
    Serum Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) and Cardiovascular Risk in Systemic Lupus Erythematosus: A Longitudinal Cohort Study
  • Abstract Number: 0662
    Serum Urate Reduction Is Causally Associated with Flare Outcomes in People with Gout: Evidence for Surrogate Status from a Pooled Analysis of 2 Randomized Trials
  • Abstract Number: 1274
    Severe Flares Are Associated with a Poorer Health-Related Quality of Life (HRQoL) in Systemic Lupus Erythematosus (SLE) Patients
  • Abstract Number: 1901
    Severe Foot Symptoms Are Associated with Mortality: The Johnston County Osteoarthritis Project
  • Abstract Number: 1655
    Severe Respiratory Infections in Rheumatoid Arthritis Patients with Biologic Therapy: Comparative Study Between Vaccinated and Non Vaccinated Patients
  • Abstract Number: 0393
    Severity and Impact of Gastrointestinal Symptoms in Patients with SSc-ILD Treated with Nintedanib: Data from SENSCIS-ON
  • Abstract Number: 1534
    Severity Factors of Covid-19 Infection in Rheumatic Immune-mediated Inflammatory Diseases: Study in a Single University Hospital
  • Abstract Number: 1847
    Severity of Gastroesophageal Reflux, but Not the Use of Proton Pump Inhibitors, Is Associated with Radiographic Progression of Interstitial Lung Disease in Systemic Sclerosis
  • Abstract Number: 0614
    Sex and Race Based Utilization of Healthcare for Ocular Inflammation and Infection: Comparing the Results from the Medicare and the IRIS Data
  • Abstract Number: 0597
    Sex Differences in Multimorbidity Between Patients with Systemic Lupus Erythematosus and Comparators in a Large Nationwide US Study
  • Abstract Number: 1242
    Sex Differences in Treatment Response to Three Different Biological Treatments and Corticosteroids in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 0299
    Sex Hormones and Risk of Sjögren’s Syndrome: Hypothesis Generating Findings Implicating Androgen and Estrogen Ratios
  • Abstract Number: 1058
    Sex-Specific Associations Between Knee Synovial Fluid Biomarkers and Knee Osteoarthritis Pain
  • Abstract Number: 1661
    Sex-Stratified Patterns of Multimorbidity at RA Onset and Associated Longitudinal Impacts on Disability Over the First Year Follow Up: Results from the Canadian Early Arthritis Cohort (CATCH)
  • Abstract Number: 0165
    Shear-Wave Elastography Evaluation of Major Salivary Glands and Correlation with B-mode Findings in Patients with Primary Sjögren’s Syndrome
  • Abstract Number: PP08
    Should I Get the COVID-19 Vaccine With My RA? Using Evidence-Based Resources for Decision-Making
  • Abstract Number: 1765
    Should SLE Patients Entering Clinical Trials Be Required to Have at Least One BILAG A and/or Two BILAG B Domain Scores?
  • Abstract Number: 0380
    Sick Leave and Its Predictors in Early Axial Spondyloarthritis: The Role of Clinical and Socioeconomic Factors. Five-year Data from the DESIR Cohort
  • Abstract Number: 1188
    Sifting Through Complexity in a Methodological Manner: Identifying Key Items in Teaching Lupus to Medical Students Through Consensus
  • Abstract Number: 1003
    Significant Enrichment of Pathogenic CD206+CD163+ Macrophages in Rheumatoid Arthritis Synovial Tissue with Distinct Transcriptional Signatures
  • Abstract Number: 0480
    Signs of Regression to the Mean in Observational Data from a Nation-Wide Exercise and Education Intervention for Osteoarthritis
  • Abstract Number: 0458
    Single Cell Profiling Reveals a Wnt-mediated Transcriptional Gradient That Drives Inflammation in Rheumatoid Arthritis Synovial Fibroblast Pathology
  • Abstract Number: 1491
    Single-cell Analysis of Paired Skin and Blood Samples from Patients with SLE and Cutaneous Lupus Suggests CD16+ DCs Arise from Non-classical Monocytes That Enter Nonlesional Skin, Undergo Type I IFN Education, and Engage in Extensive Crosstalk with Diverse Immune and Stromal Cell Types
  • Abstract Number: 1930
    Single-Cell Genomics Reveals a Shared Monocyte Interferon Program in a Subset of Patients with Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Lung Disease
  • Abstract Number: 0460
    Single-cell Profiling of B and T Cell Repertoire and Gene Expression in the RA Synovium Reveals Tissue Specific Clonal Expansion
  • Abstract Number: 0949
    Single-Cell RNA Sequencing of APS Skin Reveals Endothelial Pathology and Cellular Interactions
  • Abstract Number: 0545
    SIRT1 Modulates the Senescent Phenotype in Scleroderma Endothelial Cells
  • Abstract Number: 1845
    Six-minute Walk Test as a Prognostic Marker in Systemic Sclerosis
  • Abstract Number: 0382
    Six-year Results from the Esperanza Cohort: Evaluation of Clinical Features, Disease Activity Measures and Treatment Aspects in Axial and Peripheral Early Spondyloarthritis
  • Abstract Number: 0723
    Size of Regression to the Mean in First-Line Interventions for Osteoarthritis: An Illusion of Effectiveness
  • Abstract Number: 0315
    Sjögren’s Syndrome Symptom Diary (SSSD) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) as Assessments of Symptoms in Sjögren’s Syndrome: A Qualitative Exploration of Content Validity and Meaningful Change
  • Abstract Number: 0985
    Sjӧgren’s Symptom Burden Drives Immunomodulatory Therapies but Correlates Poorly with Disease Severity Markers
  • Abstract Number: 1935
    Skewed Escape from X-inactivation: Insights into the Female Bias of Sjögren’s Syndrome
  • Abstract Number: 1506
    SLAMF6 Compartmentalization Regulates Autoimmune T Cell Responses
  • Abstract Number: 0885
    SLE Phenotypes Formed from Machine Learning and Their Associations with Cognitive Impairment
  • Abstract Number: 1739
    SLE Treatment History and Anifrolumab Efficacy by Baseline Standard Therapies in Patients with SLE from 2 Phase 3 Trials
  • Abstract Number: 0308
    Sleep Disorders and Serum Brain-derived Neurotrophic Factor Levels in Patients with Primary Sjögren’s Syndrome
  • Abstract Number: 1590
    Sleep Disturbance Improves with SARS-COV2 Vaccinations in Patients with Rheumatologic and Chronic Inflammatory Diseases
  • Abstract Number: 0830
    Smartphone Assisted Patient Initiated Care Safely Reduces Outpatient Clinic Visits in Patients with Rheumatoid Arthritis: Results from a Randomized Controlled Trial
  • Abstract Number: 0615
    Socioeconomic Characteristics Associated with Electronic Health Care Utilization in an Urban Rheumatology Clinic During the COVID-19 Pandemic
  • Abstract Number: 0353
    Soluble Urine ALCAM Reflects Renal Disease Activity in Lupus Nephritis
  • Abstract Number: 1608
    Sources of Information About SARS-CoV-2 Used by Patients with Chronic Inflammatory Rheumatic Diseases (CIRD)
  • Abstract Number: 0513
    Spirulina Activates IFNγ via TLR4 in Dermatomyositis Skin and Peripheral Blood
  • Abstract Number: 1917
    Sputum TGF-β1 Is Elevated in Subclinical and Clinically Significant Rheumatoid Arthritis-Associated Interstitial Lung Disease and Correlates with Soluble IL-6R Levels
  • Abstract Number: 1776
    Stakeholder Outcome Prioritization in the Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis Trial
  • Abstract Number: 0688
    Standardized Prevalence Ratios of Cancer in Idiopathic Inflammatory Myositis
  • Abstract Number: 0525
    STEAP3, FZD2 and EGFLAM Are Novel Genetic Risk Loci for Granulomatosis with Polyangitis: A Genome Wide Association Study from UK Biobank
  • Abstract Number: 1644
    Storytelling of Young Adults with Chronic Rheumatologic Illnesses: A Pilot Study
  • Abstract Number: 0538
    Strengthening Nuclear Envelope Ameliorates UVB-triggered Skin Inflammation and Kidney Damage in Lupus Mice
  • Abstract Number: 0016
    Structural and Functional Neurobiological Alterations of Salience and Sensorimotor Networks in Juvenile Idiopathic Arthritis
  • Abstract Number: 0159
    Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?
  • Abstract Number: 1146
    Study of Vertebral and Femur Fracture Prevalence and Scanographic Bone Attenuation Coefficient of the First Lumbar Vertebra in an Academic Hospital Setting
  • Abstract Number: 1293
    Studying Clusters of Patients with SLE According to Cognitive Function, Self-reported Outcomes, Disease Activity, and Clusters Dynamic over 1 Year
  • Abstract Number: 1389
    Subclinical ILD Is Frequent and Progresses Across Different Connective Tissue Diseases
  • Abstract Number: 0466
    Subclinical Large Vessel Vasculitis in Polymyalgia Rheumatica
  • Abstract Number: 0090
    Subcutaneous Sarilumab in Hospitalized Patients with Moderate-severe COVID-19 Infection Compared to the Standard Care: An Open-label Randomized Clinical Trial
  • Abstract Number: 0197
    Successful Treatment of Severe COVID-19 Pneumonia with Simultaneous Tocilizumab and Anakinra – A Case Series
  • Abstract Number: 1069
    Supporting Patient-Centered Care in the Pediatric Rheumatology Setting: Patient, Family and Provider Experiences with OurNotes
  • Abstract Number: 0292
    Suppressed Paraoxonase-1 Activity and Elevated Oxylipins Associate with the Presence of Small Airways Disease in Patients with Rheumatoid Arthritis
  • Abstract Number: 0711
    Suppression of HDL-associated Apolipoprotein A-I (apoA-I) Levels in Patients with Idiopathic Inflammatory Myopathies
  • Abstract Number: 1585
    Suprascapular Nerve Block for the Treatment of Adhesive Capsulitis
  • Abstract Number: 1881
    Surgical Outcomes After Operative Procedures in Patients with Behcet’s Disease
  • Abstract Number: 1382
    Survey on Treatment Practices in Subclinical Interstitial Lung Disease in Systemic Sclerosis
  • Abstract Number: 1025
    Survival of Patients with Idiopathic Inflammatory Myopathy in Slovenia
  • Abstract Number: 0053
    Susceptibility Factors for Psoriatic Arthritis Single-cell RNA-Sequencing of Patients with Psoriatic Disease
  • Abstract Number: 0837
    Sustainability of Response Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: Results Through 3 Years from the SELECT-COMPARE Trial
  • Abstract Number: 1694
    Sustainability of Response to Upadacitinib Among Patients with Active Rheumatoid Arthritis Refractory to Biological Disease-Modifying Anti-Rheumatic Drugs
  • Abstract Number: 1458
    Sustained Efficacy and Safety of Iberdomide to Week 52 in Patients with Active Systemic Lupus Erythematosus (SLE) in a Phase 2, Randomized, Placebo-Controlled Study
  • Abstract Number: 0933
    Sustained Functional Remission in Axial Spondyloarthritis (axSpA): Which Are the Primary Outcomes That Should Be Targeted to Achieve This?
  • Abstract Number: 1350
    Sustained Improvement in Physical Function, Disease Impact and Health­-Related Quality of Life in Patients with Psoriatic Arthritis Treated with Bimekizumab: 3-Year Results from a Phase 2b Open-Label Extension Study
  • Abstract Number: 1944
    Sustained Remission/Low Disease Activity Is Feasible in the Long Term in Patients with Psoriatic Arthritis Treated with IL-23/12 Inhibition with Ustekinumab (STELARA®) and Tumor Necrosis Factor Inhibitors in a Real-World, Multicenter Study
  • Abstract Number: 0844
    Switching Biologics and Failure to Attain Remission in the First Year Predicts bDMARD Refractory Disease in Rheumatoid Arthritis: A 15-year Follow up of the Alberta Biologics Pharmacovigilance Cohort
  • Abstract Number: 1652
    Symptom Burden in Anti-citrullinated Protein Antibody Positive Individuals At-risk for Rheumatoid Arthritis Is Changing over Time and Comparable to Patients with Early Rheumatoid Arthritis
  • Abstract Number: 1371
    Symptom Management in Systemic Sclerosis: A Pilot Study of a Web-based Intervention Using Peer-Health Coaches
  • Abstract Number: 1651
    Symptom Trajectories in the Transition from Pre-Rheumatoid Arthritis to Clinically-Apparent Inflammatory Arthritis
  • Abstract Number: 1126
    Synovial Cell Dysfunction in Obese Patients May Contribute to Poor Outcomes in Knee Osteoarthritis
  • Abstract Number: 0026
    Synovial Fibroblasts Acquire a Proinflammatory and Destructive Phenotype After Exposure to αS1-Casein (CSN1S1)
  • Abstract Number: 1127
    Synovial Fluid Cytokines, Chemokines, and MMPs in Osteoarthritis Patients with Knee Pain Compared to RA Patients and Normal Knees
  • Abstract Number: 1008
    Synovial Fluid IL-36γ in Patients with Enthesitis Related Arthritis (ERA) Correlates with Disease Activity and Leads to Production of IL-6 by Fibroblast Like Synoviocytes
  • Abstract Number: 1125
    Synovial Perivascular Edema Is Associated with Altered Knee Loading Patterns During Gait in Patients with Medial Compartment-Dominant Knee Osteoarthritis
  • Abstract Number: 1232
    Synovial Tissue Lymphoid Aggregates Are Associated with Response to Rituximab Therapy in Rheumatoid Arthritis Patients
  • Abstract Number: 0218
    Synovitis Does Not Mediate the Relationship Between Body Mass Index and Progression of Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative
  • Abstract Number: 1119
    Systematic Review of Non-surgical Therapies for Hand Osteoarthritis
  • Abstract Number: 1552
    Systemic Autoimmune Conditions and Hospital Admissions in Covid-19 Infection
  • Abstract Number: 0896
    Systemic Lupus Erythematosus Disease Flares After SARS-CoV-2 Vaccination
  • Abstract Number: 0134
    Systemic Lupus Erythematosus Is a Risk Factor for Mortality in Older Patients with Early-Stage Breast Cancer
  • Abstract Number: 0861
    Systemic Lupus Erythematosus, a Pilot Study of a New Disease Activity Score
  • Abstract Number: 1292
    Systemic Lupus Erythematous Readmissions Has Reduced in the Last Decade in the United States: A 9- year Longitudinal Study of the Nationwide Readmission Database
Jump to:  View All • a b c d e f g h i j k l m n o p q r [s] t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences